scispace - formally typeset
D

David H. Kavanagh

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  10
Citations -  2527

David H. Kavanagh is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Gene & Exome. The author has an hindex of 10, co-authored 10 publications receiving 1759 citations. Previous affiliations of David H. Kavanagh include Mount Sinai Hospital.

Papers
More filters
Journal ArticleDOI

Gene expression elucidates functional impact of polygenic risk for schizophrenia

TL;DR: It is shown that schizophrenia is polygenic and the utility of this resource of gene expression and its genetic regulation for mechanistic interpretations of genetic liability for brain diseases is highlighted.
Journal ArticleDOI

The ExAC browser: displaying reference data information from over 60 000 exomes

TL;DR: The ExAC browser provides gene- and transcript-centric displays of variation, a critical view for clinical applications, and provides a variant display, which includes population frequency and functional annotation data as well as short read support for the called variant.
Journal ArticleDOI

The PsychENCODE project

Schahram Akbarian, +85 more
- 25 Nov 2015 - 
TL;DR: The PsychENCODE project aims to produce a public resource of multidimensional genomic data using tissue- and cell type–specific samples from approximately 1,000 phenotypically well-characterized, high-quality healthy and disease-affected human post-mortem brains, as well as functionally characterize disease-associated regulatory elements and variants in model systems.
Posted ContentDOI

Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia

TL;DR: Co-expression analyses identify a gene module that shows enrichment for genetic associations and is thus relevant for schizophrenia, paving the way for mechanistic interpretations of genetic liability for schizophrenia and other brain diseases.
Journal ArticleDOI

Patterns of genic intolerance of rare copy number variation in 59,898 human exomes.

TL;DR: This work characterized the rates and properties of rare genic CNVs in exome sequencing data from nearly 60,000 individuals in the Exome Aggregation Consortium (ExAC) database, and empirically estimated an index of relative intolerance to CNVs that demonstrated moderate correlation with measures of genic constraint based on single-nucleotide variation (SNV) and was independently correlated with Measures of evolutionary conservation.